John Holodnak

Sales & Marketing

John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.

News

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.